跳至主要内容
临床试验/NCT06712381
NCT06712381已完成1 期

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Skin Laser & Surgery Specialists0 个研究点目标入组 60 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
60
主要终点
Reduction of Actinic Keratoses

研究概览

简要总结

To demonstrate if Carac treatment after PDT treatment of actinic keratoses leads to superior clinical improvement when compared to Carac or PDT treatment alone. This will be done by manual counts and through photography.

详细描述

Carac has been shown to be highly effective for the treatment of actinic keratoses. Photodynamic Therapy (PDT) has also been shown to be highly effective for the treatment of actinic keratoses. Both treatments are FDA approved. The mechanism of action of each therapy is different. In general a more vigorous, but less cosmetically acceptable appearance is seen after Carac treatment as compared to PDT treatment. The purposes of this study are to determine 1) If the use of Carac, followed by PDT treatment, of actinic keratoses leads to an enhanced clinical improvement as compared to PDT treatment alone; 2) If the cosmetic appearance of the skin during Carac is improved with PDT pre-treatment; 3) Evaluate histologic changes induced by combined Carac/PDT treatment as compared to Carac treatment alone and PDT treatment alone.;4) Evaluate safety of treatments in terms of potential for infection and scarring

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males/females,, aged 40-70
  • Must have 5 or more documented facial/anterior scalp actinic keratoses
  • Read, understood, and signed informed consent form
  • Willing and able to comply with all follow-up requirements

排除标准

  • Previous treatment of facial keratoses with any modality of treatment within 3 months of study enrollment
  • Contraindications to the use of either Carac and/or PDT treatment
  • Exclusion of biopsy proven skin cancer in the area
  • Active infections or dermatitis in the treatment area

研究组 & 干预措施

1

Active Comparator

Carac

干预措施: Fluorouracil (Drug)

2

Active Comparator

Photodynamic Therapy

干预措施: Photodynamic therapy (Procedure)

3

Active Comparator

Carac combined with Photodynamic Therapy

干预措施: Carac in combination with PDT (Procedure)

结局指标

主要结局

Reduction of Actinic Keratoses

时间窗: Outcomes are assessed at 3 months

The objective of this study is to demonstrate if Carac treatment after PDT treatment of actinic keratoses leads to superior clinical improvement when compared to Carac or PDT treatment alone based on a manual lesion count.

次要结局

  • Photographic Improvement of Actinic Keratoses(Outcomes are assessed at 3 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验